In the ever-evolving landscape of global drug safety, Spain is emerging as a critical hub for pharmacovigilance (PV) services in Europe. As 2025 unfolds, the country offers a unique mix of regulatory maturity, localized expertise, and strategic relevance for pharmaceutical and biotech companies seeking compliant and efficient pharmacovigilance operations.
This article...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
